Total Payments
$3,538
2024 Payments
$435.58
Companies
28
Transactions
154
Medicare Patients
188
Medicare Billing
$11,407
Payment Breakdown by Category
Food & Beverage$3,512 (99.3%)
Other$25.59 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,512 | 153 | 99.3% |
| Honoraria | $25.59 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Marco Ophthalmic, Inc. | $624.52 | 14 | $0 (2019) |
| Allergan, Inc. | $363.61 | 14 | $0 (2022) |
| ABBVIE INC. | $315.33 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $311.53 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $202.72 | 10 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $181.62 | 10 | $0 (2021) |
| Alcon Vision LLC | $168.25 | 3 | $0 (2024) |
| Shire North American Group Inc | $147.17 | 10 | $0 (2019) |
| Lombart Brothers, Inc. | $136.38 | 3 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $121.00 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $435.58 | 19 | ABBVIE INC. ($132.08) |
| 2023 | $467.44 | 22 | ABBVIE INC. ($125.74) |
| 2022 | $546.49 | 23 | Allergan, Inc. ($221.48) |
| 2021 | $348.14 | 19 | Mallinckrodt Hospital Products Inc. ($83.25) |
| 2020 | $304.32 | 13 | Lombart Brothers, Inc. ($136.38) |
| 2019 | $442.63 | 20 | Marco Ophthalmic, Inc. ($175.07) |
| 2018 | $559.53 | 22 | Marco Ophthalmic, Inc. ($249.51) |
| 2017 | $433.51 | 16 | Marco Ophthalmic, Inc. ($199.94) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: EYE CARE | ||||||
| 10/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: EYE CARE | ||||||
| 09/17/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $121.36 | General |
| 09/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $27.92 | General |
| 06/28/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: EYE CARE | ||||||
| 06/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: EYE CARE | ||||||
| 05/02/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Honoraria | In-kind items and services | $25.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: EYE CARE | ||||||
| 04/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: EYE CARE | ||||||
| 03/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: EYE CARE | ||||||
| 03/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/14/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: OPTOMETRY | ||||||
| 01/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: EYE CARE | ||||||
| 11/30/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Ophthalmology | ||||||
| 10/27/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: EYE CARE | ||||||
| 10/17/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: EYE CARE | ||||||
| 10/05/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 45 | $6,840 | $2,322 |
| 2022 | 3 | 50 | 51 | $7,200 | $3,061 |
| 2021 | 3 | 49 | 53 | $7,680 | $3,302 |
| 2020 | 2 | 44 | 44 | $7,020 | $2,721 |
Total Patients
188
Total Services
193
Medicare Billing
$11,407
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 24 | 24 | $4,320 | $1,787 | 41.4% |
| 92250 | Photography of the retina | Office | 2023 | 21 | 21 | $2,520 | $535.54 | 21.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 18 | 18 | $3,240 | $1,755 | 54.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 13 | 14 | $1,680 | $769.77 | 45.8% |
| 92250 | Photography of the retina | Office | 2022 | 19 | 19 | $2,280 | $535.98 | 23.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 22 | 22 | $3,960 | $1,842 | 46.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 13 | 17 | $2,040 | $1,047 | 51.3% |
| 92250 | Photography of the retina | Office | 2021 | 14 | 14 | $1,680 | $413.39 | 24.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 29 | 29 | $5,220 | $2,250 | 43.1% |
| 92250 | Photography of the retina | Office | 2020 | 15 | 15 | $1,800 | $470.96 | 26.2% |
About Dr. Patrick Janson, OD
Dr. Patrick Janson, OD is a Optometrist healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366415663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Janson, OD has received a total of $3,538 in payments from pharmaceutical and medical device companies, with $435.58 received in 2024. These payments were reported across 154 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,512).
As a Medicare-enrolled provider, Janson has provided services to 188 Medicare beneficiaries, totaling 193 services with total Medicare billing of $11,407. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Columbus, OH
- Active Since 02/08/2006
- Last Updated 01/05/2009
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1366415663
Products in Payments
- OPD-III (Device) $760.90
- ACTHAR (Biological) $432.53
- XIIDRA (Drug) $316.12
- DURYSTA (Drug) $211.03
- LUMIGAN (Drug) $173.50
- RESTASIS MULTIDOSE (Drug) $148.07
- VYZULTA (Drug) $121.22
- Rhopressa (Drug) $87.87
- Monaco (Device) $85.42
- rhopressa (Drug) $78.76
- Prokera (Device) $77.84
- VUITY (Drug) $73.61
- RESTASIS (Drug) $72.73
- TYRVAYA (Drug) $68.21
- INVELTYS (Drug) $59.91
- Cequa (Drug) $57.41
- Oxervate (Drug) $55.02
- XDEMVY (Drug) $42.18
- OXERVATE (Drug) $40.49
- TEPEZZA (Biological) $35.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Columbus
Mr. Gregory Denaeyer, O.d, O.D
Optometrist — Payments: $1.1M
Optometrist $1.1M
Dr. James Oatney, Od, OD
Optometrist — Payments: $121,189
Optometrist $121,189
Dr. Erin Rueff, O.d, O.D
Optometrist — Payments: $87,322
Optometrist $87,322
Dr. Kristen Burkholder, O.d, O.D
Optometrist — Payments: $79,523
Optometrist $79,523
Dr. Douglas Bosner, Od, OD
Optometrist — Payments: $38,076
Optometrist $38,076
Dr. Abigail Menner, O.d., F.a.a.o, O.D., F.A.A.O
Optometrist — Payments: $30,314
Optometrist $30,314